Suppr超能文献

手辅助腹腔镜根治性肾切除术治疗局限性T1/T2期肾细胞癌的长期疗效

Long-term outcome of hand-assisted laparoscopic radical nephrectomy for localized stage T1/T2 renal-cell carcinoma.

作者信息

Harano Masahiko, Eto Masatoshi, Omoto Kazuya, Tatsugami Katsunori, Nomura Hiroyuki, Koga Hirofumi, Hojyo Morifumi, Yamaguchi Akito, Naito Seiji

机构信息

Department of Urology, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.

出版信息

J Endourol. 2005 Sep;19(7):803-7. doi: 10.1089/end.2005.19.803.

Abstract

PURPOSE

To evaluate the efficacy of hand-assisted laparoscopic radical nephrectomy (HALRN) in patients with localized stage T(1)/T(2) renal-cell carcinoma, we analyzed the clinical results of our patients treated in this way.

PATIENTS AND METHODS

From March 1999 to March 2003, a total of 96 patients aged 28 to 86 years (mean 61 years) with clinical stage T(1)/T(2)N(0)M(0), pathologically confirmed renal-cell carcinoma underwent HALRN. The outcomes were compared with those of open radical nephrectomy, which was performed in 86 patients from November 1991 to February 1999 in our institution. Kaplan-Meier analysis was used to analyze survival.

RESULTS

Ten patients (10.4%) had perioperative complications. During a mean follow-up of 25 months (range 6-54 months), no patients died of the cancer, although three patients had metastatic disease. The 4-year disease- free and overall survival rates were 88% and 100%, respectively. Seventy-eight patients who underwent open radical nephrectomy were followed for 38 to 156 months (median 86 months). Seventy-three survived without any recurrent disease, five survived with metastasis, and no patient died of metastatic disease. The 4-year disease-free and overall survival rates were 93% and 100%, respectively.

CONCLUSIONS

Hand-assisted laparoscopic surgical management of T(1)/T(2) renal-cell carcinoma is feasible and safe. At our institution, HALRN confers long-term oncologic effectiveness equivalent to that of open radical nephrectomy.

摘要

目的

为评估手辅助腹腔镜根治性肾切除术(HALRN)治疗局限性T(1)/T(2)期肾细胞癌患者的疗效,我们分析了采用该方法治疗的患者的临床结果。

患者与方法

1999年3月至2003年3月,共有96例年龄在28至86岁(平均61岁)、临床分期为T(1)/T(2)N(0)M(0)、病理确诊为肾细胞癌的患者接受了HALRN。将结果与1991年11月至1999年2月在本机构接受开放性根治性肾切除术的86例患者的结果进行比较。采用Kaplan-Meier分析来分析生存率。

结果

10例患者(10.4%)出现围手术期并发症。在平均25个月(范围6至54个月)的随访期间,尽管有3例患者出现转移性疾病,但无患者死于癌症。4年无病生存率和总生存率分别为88%和100%。86例接受开放性根治性肾切除术的患者随访了38至156个月(中位时间86个月)。73例患者无疾病复发存活,5例患者有转移存活,无患者死于转移性疾病。4年无病生存率和总生存率分别为93%和100%。

结论

手辅助腹腔镜手术治疗T(1)/T(2)期肾细胞癌是可行且安全的。在本机构,HALRN具有与开放性根治性肾切除术相当的长期肿瘤学疗效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验